Valeo Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:VP2 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Sep 23	Sell€90,488	Simcor Canada Holdings, Inc.	Company	520,000	€0.17
31 Aug 23	Buy€158,111	Manitex Capital Inc.	Company	892,857	€0.18
31 Aug 23	Buy€796,884	Richard MacKay	Individual	4,178,571	€0.19
31 Aug 23	Buy€681	Guy-Paul Allard	Individual	3,571	€0.19
18 Aug 23	Buy€21,711	Luc Mainville	Individual	100,000	€0.22

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.2%.

Top 12 shareholders own 54.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
25.7%	Manitex Capital Inc.	25,372,987	€2.0m	0%	no data
16.4%	Richard MacKay	16,222,751	€1.3m	0%	no data
3.08%	Luc Mainville	3,041,055	€239.0k	0%	no data
2.6%	Helen Saviuk	2,568,324	€201.9k	0%	no data
2.36%	Marc Leger	2,331,414	€183.2k	0%	no data
1.72%	Simcor Canada Holdings, Inc.	1,694,145	€133.1k	0%	no data
1.38%	Nathalie Therrien	1,358,369	€106.8k	0%	no data
0.41%	Guy-Paul Allard	400,071	€31.4k	0%	no data
0.18%	Steven Saviuk	180,745	€14.2k	0%	no data
0.18%	Robert Raich	175,000	€13.8k	0%	no data
0.022%	Nelly Komari	21,965	€1.7k	64%	no data
0.02%	Kyle Steiger	19,394	€1.5k	0%	no data